Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
initial public offering
MedTech
Tempus AI IPO drives $6.6B in VC exit value for medtech sector
Tempus AI’s IPO and Insightec, BillionToOne funding rounds bode well for the medtech sector, according to PitchBook’s Q2 report.
Emma Beavins
Aug 21, 2024 10:21am
Rapport talks up $122M IPO for proof-of-concept epilepsy trials
Jun 3, 2024 7:10am
A closer look at European biotech investment in 2024
Mar 22, 2024 8:43am
Kyverna raises IPO expectations to almost $300M
Feb 6, 2024 9:46am
Gene editing biotech Metagenomi plans modest $87M IPO
Feb 5, 2024 9:14am
Alto, Fractyl head to public markets with IPOs north of $100M
Feb 2, 2024 8:14am